The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Video Viewpoint Strategy Session: Expert Guidance on New Advances in Renal Cell Carcinoma. It has been reviewed by Bradley McGregor, MD, and Robert Motzer, MD (2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Expert Guidance on the Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer. It has been reviewed by Mark G. Kris, MD, and Nathan Pennell, MD, PhD (2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer. It has been reviewed by Sara M. Tolaney, MD, MPH; Ira J. Bleiweiss, MD; and Mikel Ross, MSN, RN, AGPCNP-BC, OCN^®, CBCN^® (2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Virtual Tumor Board: Diagnosis and Management of Myelodysplastic Syndromes. It has been reviewed by David Steensma, MD, Reza Nejati, MD, and Ilene Galinsky, BSN, MSN, ANP-C (April 2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME-approved virtual tumor board, Optimizing Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma. It has been reviewed by Loretta J. Nastoupil, MD; Reem Karmali, MD, MS; and Francisco Vega, MD, PhD (November 2020).

The clinical tools and resources contained herein are provided as educational adjuncts to the CME/NCPD-approved online activity, Virtual Tumor Board: Optimizing Personalized Care Plans for Patients With Advanced Soft Tissue Sarcoma. It has been reviewed by Vicki L. Keedy, MD, MSCI; Brian P. Rubin, MD, PhD; and Kathleen Polson, NP (2020).